Age Ayurveda Nighantu Ayurvedic practitioner? List or verify your practice

Gojihva

Onosma bracteatum Wall.

Gojihva (Onosma bracteatum Wall.) is a plant drug, from the Boraginaceae family. Not listed in WHO monographs; recognized in Ayurvedic and Unani pharmacopeias; classified as a controversial drug (Sandigdha Dravya) in some Ayurvedic texts due to identity confusion with related species.

Key facts
Botanical nameOnosma bracteatum Wall.
FamilyBoraginaceae
Pharmacopoeia statusNot listed in WHO monographs; recognized in Ayurvedic and Unani pharmacopeias; classified as a controversial drug (Sandigdha Dravya) in some Ayurvedic texts due to identity confusion with related species

The evidence at a glance

8papers on this site for this drug, published 1957 to 2025, every one with a DOI.

  • 2Other clinical studies and reviews
  • 6Laboratory and animal studies

A count is not a conclusion and a tier is a study design, not a verdict. Everything listed here is laboratory or animal work, which does not show an effect in people. Each paper is listed with what it measured on the page below. See the research index for how papers are tiered.

Names and identification

LanguageName
EnglishGojihva
Latin/BotanicalOnosma bracteatum Wall.

Key Phytochemical Constituents

  • Shikonins and onosmins (naphthoquinones - most significant)
  • Naphthazarins and benzoquinones
  • Lycopsamine and supindine viridiflorate (pyrrolizidine alkaloids in leaves)
  • Choline and tannins
  • Flavonoids and phenolic compounds
  • Saponins and glycosides

How does it work?

  • Studies of a hydro-alcoholic extract have reported anti-asthmatic activity, with mast cell stabilization and reduced bronchial hyper-responsiveness
  • Studies have reported analgesic activity, with a dose-dependent increase in latency period
  • Laboratory studies have reported anticancer mechanisms through shikonin/onosmin-mediated topoisomerase inhibition, ROS generation, and apoptosis induction
  • Studies have reported anti-inflammatory action via inhibition of pro-inflammatory mediators and stabilization of lysosomal membranes

Which traditional uses are supported by research?

These summaries come from the source notes, which do not name the studies behind them.

  • Respiratory tonic (Shvasa-hara): traditionally used as a respiratory tonic and for asthma. Studies have reported mast cell stabilization and reduced bronchial hyper-responsiveness.
  • Cooling and antipyretic (Jvarahara): traditionally used in Unani and Ayurvedic practice as a cooling herb for fever.
  • Throat and oral health (Mukha-roga): traditionally used for throat and mouth conditions. Studies have reported antimicrobial and anti-inflammatory activity.
  • Heart tonic (Hridya): traditionally used as a heart tonic.

What do recent studies show?

Only studies that could be traced to a published paper are listed here. An absence here means we could not identify the source, not that no work exists.

Recent safety updates

  • Contains pyrrolizidine alkaloids (lycopsamine, supindine viridiflorate) in leaves which are hepatotoxic with chronic use; should not be used long-term internally
  • External use generally considered safe; internal use should be limited in duration and supervised; contraindicated in liver disease patients

Dosage forms and preparation

Dosage Forms: Swarasa (fresh juice), Churna (powder), Kashayam (decoction), Tablet, Capsule, Lepa (external paste)

Standard Dosage: 10-20ml fresh juice; 3-6g powder twice daily; 50-100ml decoction twice daily; 500mg extract capsule twice daily

Optimal Timing: After meals with warm water for respiratory and urinary conditions; traditionally used as a component in compound formulations rather than standalone

Storage: Airtight containers below 25 deg C, protected from moisture and light. Label must carry appropriate PA-related warnings if applicable to jurisdiction.

Marker Compounds: Pyrrolizidine alkaloids (PA content - SAFETY MONITORING, must be below limits), Anchusine (naphthoquinone), Onosmin, Beta-sitosterol, Flavonoids, Mucilage content

Synergistic Combinations

  • With Vasa (Adhatoda) for respiratory and bronchial conditions
  • With Yashtimadhu for demulcent and anti-tussive synergy
  • With Behman (Centaurea behen) for cardiac tonic combination (Unani use)
  • With Khatmi (Althaea) for soothing urinary tract conditions

Published research

Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.

Other clinical studies and reviews2

  1. Jabbar AA, Abdullah FO, Hassan AO and others. 2022. Ethnobotanical, Phytochemistry, and Pharmacological Activity of Onosma (Boraginaceae): An Updated ReviewMolecules (Basel, Switzerland). PMID 36557820 · doi:10.3390/molecules27248687
  2. Kumar A, Attri S, Kaur S and others. 2022. Onosma L. as a source of anticancer agents: phytochemistry to mechanistic insightExploration of targeted anti-tumor therapy. PMID 36338520 · doi:10.37349/etat.2022.00109

Reviewed by Dr. Awadesh Pratap Singh, BAMS, on 11 October 2026. What that review covered.

Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.

Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.